crimean
congo
hemorrhag
fever
viru
cchfv
caus
acut
diseas
potenti
fatal
outcom
viru
preval
countri
clinic
symptom
infect
commonli
includ
fever
myalgia
hemorrhag
level
liver
enzym
rais
bleed
marker
often
increas
role
inflammatori
cytokin
pathogenesi
suggest
cchfv
employ
rang
passiv
activ
mechan
avoid
induct
antivir
type
interferon
review
recent
find
molecular
pathogenesi
interact
cchfv
type
interferon
cytokin
respons
discuss
implic
pathogenesi
diamet
approxim
nm
viru
famili
divid
five
genera
orthobunyaviru
phleboviru
hantaviru
nairoviru
tospoviru
genom
bunyavirus
consist
three
singlestrand
rna
segment
neg
polar
design
small
medium
larg
l
segment
segment
code
nucleocapsid
n
protein
member
famili
also
nonstructur
protein
nss
segment
encod
precursor
two
envelop
glycoprotein
gn
gc
case
also
nonstructur
protein
nsm
l
segment
bunyavirida
famili
code
rnadepend
rna
polymeras
termin
nucleotid
rna
segment
partial
complementari
sequenc
predict
form
stabl
pseudocircular
panhandl
structur
viral
envelop
glycoprotein
gn
gc
interact
specif
receptor
host
cell
attach
viru
enter
cell
receptordepend
endocytosi
replic
bunyavirus
take
place
cytoplasm
n
protein
interact
newli
synthes
viral
rna
form
ribonucleocapsid
turn
interact
cytoplasm
part
gn
gc
process
trigger
bud
virion
golgi
compart
nairoviru
genu
includ
describ
virus
divid
seven
differ
serotyp
crimean
congo
hemorrhag
fever
viru
cchfv
medic
import
member
genu
cchfv
etiolog
agent
human
diseas
character
fever
prostrat
sever
hemorrhag
death
first
document
outbreak
record
case
sever
hemorrhag
diseas
occur
russia
later
russian
viru
shown
antigen
ident
viru
isol
febril
patient
congo
nowaday
cchfv
known
wide
distribut
throughout
larg
area
subsaharan
africa
balcan
northern
greec
european
russia
pakistan
xinjiang
provinc
northwest
china
arabian
peninsula
turkey
iraq
iran
cchfv
second
widespread
arboviru
medic
import
dengu
viru
cchfv
also
infect
anim
remain
asymptomat
shown
cattl
sheep
goat
camel
hare
antibodi
cchfv
demonstr
sera
hors
goat
cattl
endem
area
viru
transmit
human
tick
genu
hyalomma
particular
hylomma
marginatum
marginatum
cchfv
also
isol
hyalomma
speci
human
infect
also
occur
contact
blood
tissu
materi
infect
anim
human
addit
persontoperson
transmiss
occur
via
bloodi
vomit
bodi
fluid
aerosol
patient
advanc
stage
diseas
therefor
risk
group
found
among
profess
contact
infect
anim
eg
livestock
breeder
abattoir
worker
infect
human
eg
health
care
worker
human
known
host
develop
diseas
infect
cchfv
infect
usual
result
sever
hemorrhag
fever
diseas
progress
rapid
subdivid
four
differ
stage
fig
incub
prehemorrhag
hemorrhag
convalesc
phase
incub
period
rang
day
week
length
probabl
depend
transmiss
rout
amount
inoculum
prehemorrhag
phase
usual
initi
fever
myalgia
dizzi
headach
vomit
end
averag
day
hemorrhag
fever
phase
short
character
epistaxi
bleed
gastrointestin
system
urinari
respiratori
tract
also
skin
bleed
rang
petechia
ecchymos
symptom
includ
enlarg
spleen
liver
approxim
patient
experi
averag
mortal
rate
high
sever
diseas
shown
correl
amount
viru
blood
genom
equivalentsml
blood
furthermor
shown
antibodi
respons
highli
signific
invers
correl
viral
load
convalesc
start
averag
day
post
onset
ill
phase
character
weak
loss
hair
dizzi
nausea
loss
hear
loss
memori
mention
durat
symptom
differ
phase
vari
significantli
individu
fig
pathogenesi
cchf
poorli
character
due
sever
reason
infect
occur
sporad
area
facil
limit
perform
complet
autopsi
ii
viru
handl
requir
biosafeti
level
contain
laboratori
iii
lack
avail
anim
model
diseas
limit
knowledg
cchf
pathogenesi
mostli
deriv
blood
analys
liver
biopsi
patient
use
materi
eg
small
outbreak
turkey
comprehens
studi
involv
cchf
patient
south
africa
undertaken
swanepoel
et
al
report
describ
cerebr
hemorrhag
sever
anemia
sever
dehydr
shock
associ
prolong
diarrhea
lung
edema
pleural
effus
factor
caus
fatal
outcom
almost
patient
die
develop
multipl
organ
failur
fatal
case
platelet
count
extrem
low
earli
stage
ill
increas
aspart
alanin
aminotransferas
ast
alt
level
serum
prolong
prothrombin
partial
thromboplastin
time
also
observ
effici
rapid
host
respons
virus
consist
product
type
interferon
ifnab
essenti
part
antivir
innat
immun
system
far
known
nucleat
cell
mammalian
bodi
abl
synthes
secret
type
ifn
mode
induct
type
ifn
secret
howev
differ
among
cell
type
secret
ifn
stimul
neighbour
cell
express
potent
antivir
protein
besid
role
antivir
messeng
ifn
poss
wide
rang
biolog
activ
includ
inhibit
cell
prolifer
regul
apoptosi
importantli
immunomodul
ifn
product
trigger
first
contact
viral
intrud
slow
even
stop
viru
multipl
buy
organ
time
help
establish
adapt
immun
respons
type
ifn
classifi
accord
amino
acid
sequenc
compris
larg
number
least
ifna
subtyp
singl
ifnb
well
addit
famili
member
express
pattern
ie
ifn
synthes
time
point
mostli
depend
particular
cell
type
epitheli
cell
fibroblast
neuron
mainli
secret
ifnb
initi
respons
infect
switch
ifna
subsequ
amplif
phase
ifn
respons
contrast
dendrit
cell
play
import
role
immunosurveil
provid
interfac
innat
adapt
immun
directli
produc
high
level
ifna
subtyp
ifn
induct
fibroblast
occur
mainli
intracellular
pathway
fig
hallmark
molecul
rna
virus
doublestrand
ds
rna
singlestrand
ss
rna
trigger
signal
chain
activ
ifnb
gene
express
two
rna
helicas
rigi
main
intracellular
receptor
viral
rna
rigi
recogn
differ
nonoverlap
set
virus
suggest
degre
specif
rna
recognit
inde
recent
found
rigi
uniqu
abil
bind
triphosph
group
end
uncap
viral
ssrna
moreov
rigi
bind
short
dsrna
molecul
wherea
activ
appar
depend
long
dsrna
structur
bind
viral
rna
rigi
induc
signal
chain
eventu
result
phosphoryl
transcript
factor
member
ifn
regulatori
factor
irf
famili
play
central
role
activ
ifnb
promot
phosphoryl
homodimeris
move
nucleu
initi
ifnb
mrna
synthesi
firstwav
ifn
trigger
express
relat
factor
fibroblast
present
low
amount
express
activ
lead
positivefeedback
loop
initi
synthesi
sever
ifna
subtyp
secondwav
ifn
addit
transcript
factor
nfkb
activ
rigi
diseas
progress
subdivid
four
differ
stage
differ
symptom
incub
prehemorrhag
hemorrhag
convalesc
phase
laboratori
analys
demonstr
elev
liver
enzym
aspart
alanin
aminotransferas
ast
alt
well
low
platelet
count
plt
fatal
case
dsrnadepend
kinas
pkr
activ
stressinduc
jun
kinas
trigger
viral
replic
enhanc
ifn
gene
express
myeloid
dendrit
cell
mdc
promin
plasmacytoid
dendrit
cell
pdc
main
ifn
produc
lymphat
system
mdc
sens
dsrna
classic
intracellular
pathway
addit
endosom
tolllik
receptor
tlr
pdc
predominantli
monitor
rna
viru
infect
endosom
recogn
ssrna
activ
tlr
signal
differ
intracellular
adaptor
molecul
induc
irfand
nfkbdepend
ifn
transcript
fig
ifnab
subtyp
bind
activ
common
type
ifn
receptor
present
virtual
host
cell
bind
ifnab
lead
conform
chang
intracellular
part
receptor
activ
socal
jakstat
signal
pathway
signal
transduc
activ
transcript
stat
protein
latent
cytoplasm
transcript
factor
becom
phosphoryl
janu
kinas
jak
famili
member
phosphoryl
recruit
third
factor
also
call
form
complex
known
ifn
stimul
gene
factor
heterotrim
transloc
nucleu
bind
ifnstimul
respons
element
isr
promot
region
ifnstimul
gene
isg
therebi
induc
transcript
ifnab
activ
express
ifnstimul
gene
isg
antivir
antiprolif
immunomodulatori
function
ifninduc
protein
includ
enzym
transcript
factor
cell
surfac
glycoprotein
cytokin
chemokin
larg
number
factor
unknown
function
protein
antivir
activ
character
detail
mx
gtpase
protein
kinas
r
pkr
oligoadenyl
synthetas
oa
rnasel
system
rnaspecif
adenosin
deaminas
adar
viperin
product
gene
mx
protein
belong
superfamili
dynaminlik
larg
gtpase
discov
mediat
genet
resist
orthomyxovirus
mice
human
mxa
protein
block
replic
infect
viru
soon
cell
entri
target
missort
viral
ribonucleoprotein
particl
pkr
oa
adar
constitut
express
latent
inact
form
basal
mrna
level
upregul
ifnab
enzym
need
activ
viral
dsrna
pkr
also
activ
ssrna
contain
triphosph
group
short
stemloop
pkr
serinethreonin
kinas
phosphoryl
alpha
subunit
eukaryot
translat
initi
factor
thu
block
translat
cellular
viral
mrna
oa
catalys
synthesi
short
oligoadenyl
activ
latent
endoribonucleas
rnasel
turn
degrad
viral
cellular
rna
adar
catalyz
deamin
adenosin
target
dsrna
yield
inosin
result
secondari
structur
destabil
due
chang
au
base
pair
less
stabl
iu
base
pair
mutat
accumul
within
viral
genom
viperin
local
er
membran
impair
format
lipid
raft
need
virus
replic
bud
bind
eukaryot
initi
factor
subunit
eukaryot
translat
initi
factor
function
inhibitor
translat
initi
level
ternari
complex
format
like
suppress
viral
rna
translat
ifninduc
exonucleas
specif
degrad
ssrna
vitro
cell
cultur
express
lead
reduct
vesicular
stomat
viru
vsv
influenza
viru
retroviru
replic
type
ifn
increas
interest
antivir
compound
cchfv
one
newest
addit
list
ifnsensit
virus
howev
clinic
studi
exist
far
address
effect
ifn
viral
hemorrhag
fever
includ
cchf
progress
achiev
respect
isg
affect
cchfv
replic
mxa
significantli
contribut
antivir
activ
ifn
cchfv
similar
observ
member
bunyavirida
mxa
found
coloc
interact
cchfv
nucleocapsid
protein
perinuclear
region
infect
cell
interact
like
respons
inhibit
viru
replic
similar
mxan
interact
known
bunyavirus
like
bunyavirus
may
restrict
intracellular
growth
mxa
probabl
mechan
howev
use
sirna
approach
deplet
cell
mxa
could
demonstr
mxa
sole
player
ifninduc
antivir
activ
cchfv
recent
studi
indic
contribut
pkr
manuscript
prepar
thu
appar
sever
isg
antivir
activ
cchfv
probabl
act
concert
combat
infect
despit
strongli
inhibit
type
ifn
cchfv
still
run
devast
cours
human
host
estim
cchfv
mortal
rang
percent
like
explan
discrep
virusinduc
ifn
therapeut
prophylact
effect
product
ifn
infect
cell
ineffici
fact
recent
data
show
mechan
seem
place
shown
ifn
signific
activ
alreadi
establish
cchfv
infect
treatment
cell
uml
ifn
h
infect
ineffect
wherea
dose
appli
infect
result
signific
inhibit
cchfv
replic
indic
cchfv
strongli
counteract
ifn
signal
experi
underway
clarifi
issu
addit
cchfvappear
counteract
induct
ifn
synthesi
sever
independ
strategi
firstli
conceiv
similar
negativestrand
rna
virus
bunyavirus
cchfv
produc
signific
amount
ifn
induc
molecul
dsrna
ongo
studi
aim
test
assumpt
secondli
found
import
rigi
signal
pathway
trigger
viral
ssrna
carri
triphosph
activ
cchfv
genom
wherea
ssrna
genom
relat
rift
valley
fever
viru
rvfv
contain
triphosph
group
induc
ifn
induct
via
rigi
cchfv
genom
contain
rigineutr
monophosph
like
cchfv
cleav
triphosph
group
genom
replic
order
escap
recognit
rigi
line
ifn
induct
cchfvinfect
cell
weak
occur
rel
late
member
famili
bunyavirida
therefor
appear
evolv
two
radic
differ
strategi
inhibit
rigi
pathway
wherea
rvfv
inhibit
ifn
induct
express
dedic
antiifn
factor
nonstructur
protein
nss
cchfv
remov
rigi
ligand
genom
bunyavirus
fall
categori
eg
la
cross
viru
express
nss
protein
block
ifn
induct
hantaan
viru
contain
monophosph
genom
end
nonetheless
ifnactiv
structur
rna
seem
present
cchfv
particl
viru
possess
also
least
one
antiifn
factor
experi
use
uv
irradi
reveal
gene
weakli
activ
uvinactiv
cchfv
particl
earli
time
point
infect
upregul
envelop
viral
particl
describ
occur
unknown
tlrand
rigiindepend
signal
pathway
cell
infect
intact
viru
contrast
upregul
occur
delay
h
line
intact
viru
delay
activ
assay
measur
nuclear
transloc
approxim
h
indic
cchfv
express
factor
counteract
activ
henc
upregul
factor
known
far
sequenc
analys
suggest
cchfv
capac
encod
addit
gene
segment
data
shown
correspond
protein
product
yet
identifi
besid
demonstr
l
protein
cchfv
contain
ovarian
tumor
otu
domain
allow
innat
immun
evas
domain
also
present
l
protein
relat
nairovirus
dugb
viru
nairobi
sheep
diseas
viru
phylogenet
distant
phleboviru
rvfv
otu
domain
repres
superfamili
ubiquitin
ub
deconjug
proteas
found
prokaryot
eukaryot
virus
ub
interferonstimul
gene
product
short
protein
coval
conjug
protein
mediat
innat
antivir
respons
friasstah
et
al
show
otu
domaincontain
proteas
cchfv
relat
nairovirus
deconjug
ub
cellular
target
protein
moreov
express
viral
otu
domaincontain
protein
antagon
antivir
effect
inhibit
nfkbdepend
signal
thu
cchfv
employ
rang
strategi
evad
counteract
innat
immun
repons
fig
rigi
recognit
circumv
remov
triphosph
group
viral
genom
activ
mediat
particl
recognit
pathway
delay
yet
identifi
viral
factor
nfkappab
activ
antivir
action
downregul
otu
domain
l
protein
viral
strategi
antagon
innat
immun
respons
usual
perfect
mostli
delay
rather
complet
suppress
ifn
system
common
suggest
featur
agent
caus
hemorrhag
fever
deregul
host
immun
respons
combat
attack
cell
involv
initi
antivir
respons
exist
knowledg
concern
cchf
eman
autopsi
clinic
find
primari
pathophysiolog
event
appear
leakag
erythrocyt
plasma
vasculatur
tissu
endotheli
damag
contribut
coagulopathi
deregul
stimul
platelet
aggreg
turn
activ
intrins
coagul
cascad
ultim
lead
clot
factor
defici
caus
hemorrhag
cchfv
vascular
leakag
may
caus
either
destruct
endotheli
cell
disrupt
tight
junction
constitut
endotheli
barrier
cell
moreov
unclear
whether
event
direct
consequ
infect
whether
virusinduc
host
factor
caus
endotheli
dysfunct
howev
epitheli
cell
line
model
cchfv
neither
caus
disrupt
tight
junction
necrosi
apoptosi
cell
could
suggest
hemorrhag
coagul
disturb
may
caus
indirectli
possibl
high
level
proinflammatori
cytokin
fact
hemorrhag
fever
virus
like
ebola
dengu
viru
correl
strength
proinflammatori
respons
vascular
leakag
diseas
sever
key
player
diseas
progress
cytokin
interleukin
il
tumour
necrosi
factor
tnf
shown
yellow
fever
patient
fatal
outcom
high
level
tnfa
anoth
studi
earli
elev
level
beta
ebola
virusinfect
patient
correl
nonfat
outcom
wherea
releas
high
level
neopterin
ilra
plasma
correl
fatal
outcom
recent
ergonul
cowork
demonstr
significantli
higher
level
tnfa
cchfv
patient
fatal
outcom
compar
nonfat
case
anoth
observ
correl
high
level
tnfa
onset
dissemin
intravascular
coagul
dic
patient
howev
elev
level
observ
patient
level
neg
correl
dic
score
anoth
studi
papa
et
al
confirm
high
tnfa
level
correl
sever
cchf
diseas
fig
countermeasur
cchfv
escap
type
ifn
respons
end
cchfv
ssrna
genom
contain
triphosph
group
characterist
negativestrand
rna
virus
rather
monophosphoryl
recognit
receptor
rigi
bind
monophosphoryl
ssrna
henc
unabl
trigger
ifn
respons
like
negativestrand
rna
virus
cchfv
like
produc
signific
amount
dsrna
thu
render
rigi
pkr
pathway
inact
pkr
possibl
nonetheless
activ
either
trace
amount
dsrna
cell
stress
result
infect
contact
uvinactiv
cchfv
particl
trigger
unknown
mechan
counter
product
infect
cell
yet
identifi
viral
factor
cchfv
l
segment
code
otu
domain
ubiquitin
ub
deconjug
proteas
antagon
antivir
effect
inhibit
nfkbdepend
signal
suggest
could
found
mild
sever
case
fatal
case
studi
high
level
tnfa
compar
nonfat
case
anoth
interest
observ
elev
level
neopterin
patient
dengu
fever
ebola
hemorrhag
fever
neopterin
deriv
produc
macrophag
dendrit
cell
upon
stimul
ifn
neopterin
use
tool
assess
intens
cellmedi
immun
respons
recent
studi
inde
note
correl
elev
level
neopterin
cchfv
patient
diseas
sever
result
suggest
capillari
fragil
common
featur
cchf
probabl
due
multipl
hostinduc
mechan
respons
cchfv
infect
endotheli
damag
would
caus
characterist
rash
contribut
hemostat
failur
interestingli
author
notic
similar
variou
viral
hemorrhag
fever
septic
shock
caus
sever
bacteri
infect
research
cchfv
hamper
sever
constraint
firstli
work
viru
requir
contain
facil
highest
secur
standard
possibl
secondli
anim
model
mimic
human
diseas
thirdli
cchf
case
occur
sporad
clinic
sampl
rare
use
avail
system
howev
press
question
cchfv
address
near
futur
molecular
pattern
elicit
activ
cchfv
treatment
fibroblast
uvirradi
viru
particl
activ
genom
cchfv
lack
triphosph
group
trigger
rigi
structur
eg
viral
envelop
particl
nucleocapsid
must
recogn
infect
cell
tlr
involv
cchfv
recognit
cytokin
induct
vivo
dc
infect
role
cytokin
respons
cchfv
nsslike
gene
suppress
ifn
cytokin
induct
bunyavirus
genera
orthobunyaviru
phlebovirus
eg
la
cross
viru
bunyamwera
viru
rift
valley
fever
viru
nonstructur
protein
encod
segment
nss
known
strongli
suppress
transcript
activ
ifn
induc
gene
moreov
member
hantaviru
genu
also
encod
nss
protein
weakli
supress
ifn
induct
moreov
hantavirus
known
glycoprotein
interfer
ifn
induct
delay
activ
observ
product
infect
cell
indic
cchfv
encod
protein
domain
dedic
counteract
ifn
induct
cchfv
interfer
ifn
signal
viral
gene
product
respons
ifn
effect
given
advanc
given
h
infect
therefor
conceiv
cchfv
capabl
shut
jakstat
pathway
isg
contribut
inhibit
cchfv
ifn
isg
besid
mxa
perhap
pkr
may
effici
block
variou
step
cchfv
replic
role
otu
domain
pathogenesi
current
revers
genet
system
avail
gener
infecti
virus
clone
cdna
plasmid
mutat
inactiv
otu
domain
rescu
respect
viru
phenotyp
comparison
wildtyp
viru
reveal
contribut
otu
domain
viru
replic
cell
cultur
vivo
viru
caus
vascular
leakag
mention
endothelium
target
two
waysindirectli
virusmedi
hostderiv
factor
caus
endotheli
dysfunct
andor
directli
viru
infect
endotheli
cell
recent
studi
demonstr
increas
level
tnfa
correl
diseas
sever
suggest
endotheli
damag
may
due
cytokin
storm
date
experiment
studi
investig
whether
viru
replic
cycl
per
se
whether
cytokin
damag
tight
junction
endotheli
cell
answer
question
would
certainli
improv
knowledg
cchfv
pathogenesi
open
new
way
prevent
treatment
hemorrhag
fever
caus
highli
virul
pathogen
